Skip to content

HNGE HNGE Stock-Based Comp

Stock-Based Comp at other companies

Globus Medical logo
Globus MedicalGMED
$12.62M-4.5%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$36.86M+48.3%
Stryker logo
StrykerSYK
$87M+3.6%
Solventum logo
SolventumSOLV
$51M+4.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.2M+23.5%
Medtronic logo
MedtronicMDT
$95M+6.7%

Segments

By segment

See full
Reportable Segment$11.69M+166,929%

Other financials

Income statement

See full
Revenue$182.3M+47.2%
Gross profit$154.2M+53.9%
Operating income$32.1M+144%
Net income$35.1M+105%
EPS (diluted)$0.41-68.7%

Balance sheet

See full
Cash & equivalents$188.1M-35.2%
Total debt$7.0M
Total equity$111.7M+136%
Total assets$728.8M

Cash flow

See full
Operating cash flow$43.1M+775%
CapEx$83.0K+62.7%
Free cash flow$43.0M+782%

Valuation

See full
Market cap$5.37B

Profitability

See full
Gross margin80.8%+1.5pp
Operating margin-85.8%
Net margin-83.9%
FCF margin32.3%

Returns & leverage

See full
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HNGE's stock-based comp?
HNGE (HNGE) reported stock-based comp of $11.69M in Q1 2026.
How has HNGE's stock-based comp changed year-over-year?
HNGE's stock-based comp increased by 166928.6% year-over-year, from $7K to $11.69M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.